WallStreetZenWallStreetZen

NASDAQ: NAUT
Nautilus Biotechnology Inc Stock Ownership - Who owns Nautilus Biotechnology?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Nautilus Biotechnology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Sujal M. PatelCEO President and Secretary2025-09-0883,500$0.68
$57.03kBuy
Sujal M. PatelCEO President and Secretary2025-09-05116,500$0.67
$78.52kBuy
Matthew B. MurphyGeneral Counsel2025-09-0420,000$0.64
$12.86kBuy
Anna MowryCFO and Treasurer2025-05-2915,000$0.77
$11.49kBuy
Parag MallickChief Scientist2025-05-121,500$0.73
$1.10kBuy
Parag MallickChief Scientist2025-05-0812,000$0.73
$8.78kBuy
Sujal M. PatelCEO President and Secretary2025-03-2023,933$1.00
$23.89kBuy
Sujal M. PatelCEO President and Secretary2025-03-1953,300$1.00
$53.03kBuy
Mary E. GodwinSenior VP Operations2024-09-2347,031$2.87
$134.74kSell
Mary E. GodwinSenior VP Operations2024-09-2347,031$0.46
$21.63kBuy

1 of 1

NAUT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NAUT insiders and whales buy or sell their stock.

NAUT Shareholders

What type of owners hold Nautilus Biotechnology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Parag Mallick16.23%20,493,392$15.86MInsider
Sujal M. Patel15.24%19,250,267$14.90MInsider
Vijay Satyanand Pande13.98%17,653,917$13.66MInsider
Ah Equity Partners Bio II LLC13.98%17,653,917$13.66MInsider
Ah Capital Management LLC13.98%17,653,917$13.66MInstitution
Perceptive Advisors LLC9.97%12,594,211$9.75MInstitution
Perceptive Advisors LLC7.21%9,111,151$7.05MInsider
Cercano Management LLC5.68%7,172,985$5.55MInstitution
Matthew S. McIlwain5.13%6,479,845$5.02MInsider
Madrona Venture Group LLC4.77%6,020,770$4.66MInstitution

1 of 3

NAUT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NAUT39.13%60.87%Net BuyingNet Buying
COYA26.81%12.91%Net BuyingNet Buying
PLRX66.21%33.79%Net Selling
ORMP17.68%51.57%
KLRS4.47%95.53%Net Selling
View Top Biotech Stocks

Nautilus Biotechnology Stock Ownership FAQ

Who owns Nautilus Biotechnology?

Nautilus Biotechnology (NASDAQ: NAUT) is owned by 47.31% institutional shareholders, 73.60% Nautilus Biotechnology insiders, and 0.00% retail investors. Parag Mallick is the largest individual Nautilus Biotechnology shareholder, owning 20.49M shares representing 16.23% of the company. Parag Mallick's Nautilus Biotechnology shares are currently valued at $15.37M.

If you're new to stock investing, here's how to buy Nautilus Biotechnology stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.